GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocon Ltd (BOM:532523) » Definitions » 3-Year EBITDA Growth Rate

Biocon (BOM:532523) 3-Year EBITDA Growth Rate : 33.70% (As of Mar. 2025)


View and export this data going back to 2004. Start your Free Trial

What is Biocon 3-Year EBITDA Growth Rate?

Biocon's EBITDA per Share for the three months ended in Mar. 2025 was ₹9.38.

During the past 12 months, Biocon's average EBITDA Per Share Growth Rate was 9.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 33.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 22.30% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 16.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Biocon was 33.70% per year. The lowest was 2.30% per year. And the median was 15.90% per year.


Competitive Comparison of Biocon's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Biocon's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biocon's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biocon's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Biocon's 3-Year EBITDA Growth Rate falls into.


;
;

Biocon 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Biocon  (BOM:532523) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Biocon 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Biocon's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Biocon Business Description

Industry
Traded in Other Exchanges
Address
20th KM, Hosur Road, Electronics City, Bengaluru, KA, IND, 560100
Biocon Ltd is a biopharmaceutical company that develops biotechnology therapies for diseases. The company is focused on developing, manufacturing, and supplying novel and biosimilar pharmaceuticals for diabetes, cancer, and autoimmune conditions. Biocon has four reportable segments: Biosimilars which derives maximum revenue, Generics, Novel Biologics (Novels), and Research services (Research). The company provides integrated contract research and manufacturing services to pharmaceutical and biotechnology companies through its subsidiary Syngene. Geographically, the company generates a majority of its revenue from its customers located in India and the rest from Brazil, Singapore, and the rest of the world.

Biocon Headlines

No Headlines